Literature DB >> 19564528

African American women who receive primary anthracycline- and taxane-based chemotherapy for triple-negative breast cancer suffer worse outcomes compared with white women.

Ani Balmanoukian, Zhe Zhang, Stacie Jeter, Shannon Slater, Deborah K Armstrong, Leisha A Emens, John H Fetting, Antonio C Wolff, Nancy E Davidson, Lisa Jacobs, Julie Lange, Theodore N Tsangaris, Richard Zellars, Edward Gabrielson, Vered Stearns.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19564528      PMCID： PMC4813786          DOI： 10.1200/JCO.2008.21.5509

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  7 in total

Review 1.  Proceedings of the consensus conference on neoadjuvant chemotherapy in carcinoma of the breast, April 26-28, 2003, Philadelphia, Pennsylvania.

Authors:  Gordon F Schwartz; Gabriel N Hortobagyi
Journal:  Cancer       Date:  2004-06-15       Impact factor: 6.860

2.  Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study.

Authors:  Lisa A Carey; Charles M Perou; Chad A Livasy; Lynn G Dressler; David Cowan; Kathleen Conway; Gamze Karaca; Melissa A Troester; Chiu Kit Tse; Sharon Edmiston; Sandra L Deming; Joseph Geradts; Maggie C U Cheang; Torsten O Nielsen; Patricia G Moorman; H Shelton Earp; Robert C Millikan
Journal:  JAMA       Date:  2006-06-07       Impact factor: 56.272

3.  Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: an update.

Authors:  Manfred Kaufmann; Gabriel N Hortobagyi; Aron Goldhirsch; Suzy Scholl; Andreas Makris; Pinuccia Valagussa; Jens-Uwe Blohmer; Wolfgang Eiermann; Raimund Jackesz; Walter Jonat; Annette Lebeau; Sibylle Loibl; William Miller; Sigfried Seeber; Vladimir Semiglazov; Roy Smith; Rainer Souchon; Vered Stearns; Michael Untch; Gunter von Minckwitz
Journal:  J Clin Oncol       Date:  2006-04-20       Impact factor: 44.544

4.  The role of ultrasound-guided fine-needle aspiration of axillary nodes in the staging of breast cancer.

Authors:  Ajay Jain; Mary Ellen Haisfield-Wolfe; Julie Lange; Nita Ahuja; Nagi Khouri; Theodore Tsangaris; Zhe Zhang; Charles Balch; Lisa K Jacobs
Journal:  Ann Surg Oncol       Date:  2007-11-06       Impact factor: 5.344

5.  Triple receptor-negative breast cancer: the effect of race on response to primary systemic treatment and survival outcomes.

Authors:  Shaheenah Dawood; Kristine Broglio; Shu-Wan Kau; Marjorie C Green; Sharon H Giordano; Funda Meric-Bernstam; Thomas A Buchholz; Constance Albarracin; Wei T Yang; Bryan T J Hennessy; Gabriel N Hortobagyi; Ana Maria Gonzalez-Angulo
Journal:  J Clin Oncol       Date:  2008-12-01       Impact factor: 44.544

6.  Trends in survival over the past two decades among white and black patients with newly diagnosed stage IV breast cancer.

Authors:  Shaheenah Dawood; Kristine Broglio; Ana M Gonzalez-Angulo; Aman U Buzdar; Gabriel N Hortobagyi; Sharon H Giordano
Journal:  J Clin Oncol       Date:  2008-08-25       Impact factor: 44.544

7.  Race and triple negative threats to breast cancer survival: a population-based study in Atlanta, GA.

Authors:  Mary Jo Lund; Katrina F Trivers; Peggy L Porter; Ralph J Coates; Brian Leyland-Jones; Otis W Brawley; Elaine W Flagg; Ruth M O'Regan; Sheryl G A Gabram; J William Eley
Journal:  Breast Cancer Res Treat       Date:  2008-03-07       Impact factor: 4.872
  7 in total
  10 in total

1.  Recruitment of African Americans to National Oncology Clinical Trials through a clinical trial shared resource.

Authors:  Debra Wujcik; Steven N Wolff
Journal:  J Health Care Poor Underserved       Date:  2010-02

Review 2.  Breast cancer in Latinas: gene expression, differential response to treatments, and differential toxicities in Latinas compared with other population groups.

Authors:  Tejal A Patel; Gerardo Colon-Otero; Celyne Bueno Hume; John A Copland; Edith A Perez
Journal:  Oncologist       Date:  2010-04-28

3.  Pathologic complete response in breast cancer patients receiving anthracycline- and taxane-based neoadjuvant chemotherapy: evaluating the effect of race/ethnicity.

Authors:  Mariana Chavez-Macgregor; Jennifer Litton; Huiqin Chen; Sharon H Giordano; Clifford A Hudis; Antonio C Wolff; Vicente Valero; Gabriel N Hortobagyi; Melissa L Bondy; Ana Maria Gonzalez-Angulo
Journal:  Cancer       Date:  2010-09-01       Impact factor: 6.860

Review 4.  Interactions among genes, tumor biology and the environment in cancer health disparities: examining the evidence on a national and global scale.

Authors:  Tiffany A Wallace; Damali N Martin; Stefan Ambs
Journal:  Carcinogenesis       Date:  2011-04-03       Impact factor: 4.944

5.  Does race affect outcomes in triple negative breast cancer?

Authors:  Jasgit C Sachdev; Saira Ahmed; Muhammad M Mirza; Aamer Farooq; Lori Kronish; Mohammad Jahanzeb
Journal:  Breast Cancer (Auckl)       Date:  2010-05-07

6.  Impact of race, ethnicity, and BMI on achievement of pathologic complete response following neoadjuvant chemotherapy for breast cancer: a pooled analysis of four prospective Alliance clinical trials (A151426).

Authors:  Erica T Warner; Karla V Ballman; Carrie Strand; Judy C Boughey; Aman U Buzdar; Lisa A Carey; William M Sikov; Ann H Partridge
Journal:  Breast Cancer Res Treat       Date:  2016-07-22       Impact factor: 4.872

7.  Prognostic factors for response to cisplatin-based chemotherapy in advanced cervical carcinoma: a Gynecologic Oncology Group Study.

Authors:  David H Moore; Chunqiao Tian; Bradley J Monk; Harry J Long; George A Omura; Jeffrey D Bloss
Journal:  Gynecol Oncol       Date:  2009-10-22       Impact factor: 5.482

8.  Racial and ethnic disparities in a national cohort of ampullary cancer patients.

Authors:  Ibrahim Nassour; Ali A Mokdad; Rebecca M Minter; Patricio M Polanco; Mathew M Augustine; John C Mansour; Matthew R Porembka; Sam C Wang
Journal:  J Surg Oncol       Date:  2017-10-02       Impact factor: 3.454

9.  Increased sensitivity of African American triple negative breast cancer cells to nitric oxide-induced mitochondria-mediated apoptosis.

Authors:  Luis Martinez; Easter Thames; Jinna Kim; Gautam Chaudhuri; Rajan Singh; Shehla Pervin
Journal:  BMC Cancer       Date:  2016-07-29       Impact factor: 4.430

Review 10.  Health Behaviors and Lifestyle Interventions in African American Breast Cancer Survivors: A Review.

Authors:  Raheem J Paxton; William Garner; Lorraine T Dean; Georgiana Logan; Kristen Allen-Watts
Journal:  Front Oncol       Date:  2019-01-22       Impact factor: 6.244
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.